VANCOUVER, April 25 /CNW/ - iCo Therapeutics Inc. (TSX-V: ICO) announces
that the company's Diabetic Macular Edema (DME) candidate, "iCo-007", will be
presented by Dr. Peter Hnik in a poster session at the Association for
Research in Vision and Ophthalmology Annual Meeting (ARVO).
